Heparitin Sulfate

surface glycoprotein ; Severe acute respiratory syndrome coronavirus 2







19 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35020256 Charge Matters: Mutations in Omicron Variant Favor Binding to Cells. 2022 Mar 18 1
2 35054983 Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission. 2022 Jan 12 2
3 35060381 Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II. 2022 Feb 14 2
4 35169535 Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. 2022 Feb 11 1
5 35269476 The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get? 2022 Mar 2 1
6 35440680 Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection. 2022 Apr 15 5
7 33514685 Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection. 2021 Jan 29 1
8 33791697 The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. 2021 Mar 26 2
9 33915212 Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. 2021 Jul 31 1
10 33968333 Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain. 2021 2
11 34013835 Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate. 2021 Dec 3
12 34179075 Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer. 2021 2
13 34200372 ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. 2021 Jun 7 1
14 34235261 Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2. 2021 Jun 23 2
15 34356644 COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? 2021 Jul 13 1
16 34743814 SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. 2021 Dec 15 3
17 32699853 SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. 2020 Jul 14 4
18 32970989 SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. 2020 Nov 12 3
19 33298900 Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. 2020 Nov 4 4